Anika Therapeutics(CH:AKP)
CH:AKP
Anika Therapeutics earnings date
Anika Therapeutics (AKP) Q2 2022 Earnings Report
0 Followers
CH:AKP Q2 2022 EPS Results
- Actual EPS
- -CHF 0.17
- Consensus EPS
- -CHF 0.19
- Beat/Miss
- Beat by +CHF 0.02
- One Year Ago EPS
- CHF 0.38
CH:AKP Q2 2022 Revenue Results
- Actual Revenue
- CHF 33.13M
- Expected Revenue
- CHF 31.62M
- Beat/Miss
- Beat by +CHF 1.51M
- YoY Revenue Growth
- +3.96%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/03/2022
- Time
- After Close
- Conference Call
- Wednesday, August 3, 2022
CH:AKP Upcoming Earnings
Anika Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:AKP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | 0.11- | 0.26 | ― | ― |
| Nov 06, 2026 | 2026 (Q3) | 0.350.24 | 0.03 | 625.00% (+0.21) | |
| Jul 29, 2026 | 2026 (Q2) | 0.030.35 | -0.11 | 423.08% (+0.46) | |
| Apr 29, 2026 | 2026 (Q1) | 0.000.23 | -0.05 | 550.00% (+0.28) | |
| Feb 26, 2026 | 2025 (Q4) | -0.100.26 | -0.03 | 1133.33% (+0.28) | |
| Nov 05, 2025 | 2025 (Q3) | -0.150.03 | -0.21 | 116.00% (+0.24) | |
| Jul 30, 2025 | 2025 (Q2) | -0.22-0.11 | 0.14 | -176.47% (-0.25) | |
| May 09, 2025 | 2025 (Q1) | -0.08-0.05 | 0.08 | -166.67% (-0.13) | |
| Mar 12, 2025 | 2024 (Q4) | -0.19-0.03 | 0.04 | -160.00% (-0.07) | |
| Oct 31, 2024 | 2024 (Q3) | 0.08-0.21 | 0 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
